Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03036215 · ClinicalTrials.gov registry record · NA
Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology
A NA study of Temporomandibular Joint Dysfunction Syndrome, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03036215: Completed NA study of Temporomandibular Joint Dysfunction Syndrome, sponsored by HealthPartners Institute.
NCT03036215 is a NA study of Temporomandibular Joint Dysfunction Syndrome that has completed, run by HealthPartners Institute. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03036215, a NA study of Temporomandibular Joint Dysfunction Syndrome, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot project is to determine the feasibility and acceptability of proposed methods for a subsequent clinical trial of a tailored self-management program (PACT) designed to decrease pain in participants with temporomandibular disorders (TMD). The PACT program is a personalized program of exercise and behavioral changes implemented through a web-based program supported by a health coach. For this feasibility and acceptability study, 80 adults with TMD pain will be randomized either to the PACT program or to traditional self-care.
Primary Outcome
Measure: Graded Chronic Pain Scale (GCPS) with mean intensity ratings for reported current, worst, and average pain. 3 items: Scale 0-100 (100 most severe)
Conditions Studied
Interventions
- BEHAVIORAL PACT Experimental Arm
Study Locations (1)
Minnesota
- HealthPartners Clinic - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2017-11-09 |
| Phase | NA |
What the finished NCT03036215 record still lists
NCT03036215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Temporomandibular Joint Dysfunction Syndrome appearing as the primary indexed condition, and to 1 intervention - of which PACT Experimental Arm is the first listed.
NCT03036215 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03036215 about?
NCT03036215 is a clinical study titled "Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology". The purpose of this pilot project is to determine the feasibility and acceptability of proposed methods for a subsequent clinical trial of a tailored self-management program (PACT) designed to decrease pain in participants with temporomandibular disorders (TMD). The PACT program is a personalized pr...
What is the current status of trial NCT03036215?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-05-08. Estimated completion is 2017-11-09.
What conditions does trial NCT03036215 study?
This clinical trial studies the following conditions: Temporomandibular Joint Dysfunction Syndrome.
What interventions are being tested in trial NCT03036215?
The interventions under investigation include: PACT Experimental Arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT03036215?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03036215 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03036215's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI